Managing Director, DBH Investment
Dr. Ürge was appointed as the CEO of ThalesNano in March 2007 and held this position until April 2012. In 2006 he was the Vice President of European Operations for AMRI Hungary. From 2001 to 2006 Dr. Ürge was the CEO of ComGenex Inc, an integrated drug discovery service provider. Earlier he held the position of Head of Pharmaceutical development at Biorex R&D Inc, an innovative biotechnology company in the US. Prior to that he was a research group leader at Neurex Corporation (CA, USA) later acquired by Elan Pharmaceuticals.
He did his postdoc at the Wistar Institute in Philadelphia and at Brandeis University in Waltham, MA. He is a Vice President of the Hungarian Association for Innovation and a Member of the Board of the Hungarian Biotechnology Association. Dr. Ürge is author of 90 publications and patents and a holder of two R&D awards.